Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies
Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding lapse notice as well as Revision: v3.4.1 from the page.SummaryDifference0.2%

- Check41 days agoChange DetectedSite-wide notice about government funding and NIH Clinical Center status has been added, with links to cc.nih.gov and opm.gov. The page revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedShow glossary toggle added; QC-related label updated to 'Last Update Submitted that Met QC Criteria', capitalization adjusted for 'No FEAR Act Data', and the revision tag changed to 'Revision: v3.4.0' (replacing v3.3.4).SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3; this change is limited to metadata and does not alter page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was updated with new trial sites across the United States and internationally, and several existing locations were removed.SummaryDifference2%

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.